Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >> A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]
Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD
Tue, Feb 21, 2023 2:00 PM – 3:00 PM EST Presenters: Jessica Paulus, ScD, VP of Research, OM1 and Anna Swenson, Senior Epidemiologist, OM1 Register >> Structured data, what’s found in an electronic medical record or claims, and unstructured data, what’s found in clinician notes, provide valuable insights into treatment effectiveness and safety, gaps in[…]
2022 has been a busy and productive year for OM1 in Real-World Data (RWD), Real-World Evidence (RWE), and Artificial Intelligence (AI). In this debut newsletter, we highlight industry trends and how OM1 is rising to meet those challenges and innovating to develop new opportunities. Please complete the form to download the newsletter. Download >> *Due[…]
In this episode of the Medical Affairs Professional Society (MAPS) podcast ELEVATE, Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 discusses how Artificial Intelligence can accelerate diagnosis and treatment. Listen to the Full Episode >>
